Jacob Bishop, MD
Psychiatry · Lexington, KYNPI 1013324136
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $43,920 of the $56,420 with a category attached, or 77.8%. Alkermes, Inc. accounts for 97.9% of it on its own, with 13 other manufacturers making up the rest. 2025 is the largest year on record at $54,687, more than ten times the $157 reported in 2019. Among psychiatry clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 193 payments — averaging $292.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$55K
- Johnson & Johnson$488
- Otsuka America Pharmaceutical, Inc.$181
- Indivior Inc.$116
- Lundbeck LLC$84
- Bioxcel Therapeutics, Inc.$59
- plus $274 from 8 others
What the payments were for
- Consulting fees$6,31011%
- Speaking & faculty fees$43,92078%
- Travel & lodging$3,2456%
- Food & beverage$2,9465%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 130 | $55,219 |
| Johnson & Johnson | 23 | $488 |
| Otsuka America Pharmaceutical, Inc. | 10 | $181 |
| Indivior Inc. | 7 | $116 |
| Lundbeck LLC | 5 | $84 |
| Bioxcel Therapeutics, Inc. | 3 | $59 |
| E.r. Squibb & Sons, L.L.C. | 3 | $57 |
| AbbVie | 2 | $52 |
| Ironshore Pharmaceuticals Inc. | 3 | $46 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| Teva Pharmaceuticals USA, Inc. | 2 | $30 |
| Neurocrine Biosciences, Inc. | 1 | $19 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $17 |
| Vanda Pharmaceuticals Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$56,420 in reported general payments places this provider in the 95th percentile of 348 psychiatry providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mirtazapine | 15 | $209 |
| Quetiapine Fumarate | 31 | $126 |
| Trazodone Hcl | 22 | $62 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Lexington
- Mark WrightLexington$637K
- Steven CroleyLexington$151K
- Andrew CooleyLexington$47K
- Syed RizviLexington$17K
- Michelle LofwallLexington$11K
- Saeed HamidLexington$10K
- Getulio TovarLexington$5K
- Brian KeltyLexington$4K
- Andre FernandezLexington$4K
- Carmen PintoElizabethtown$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.